181 related articles for article (PubMed ID: 3234616)
1. Comparison of the gastric antisecretory and antiulcer potencies of telenzepine, pirenzepine, ranitidine and cimetidine in the rat.
Riedel R; Bohnenkamp W; Eltze M; Heintze K; Prinz W; Kromer W
Digestion; 1988; 40(1):25-32. PubMed ID: 3234616
[TBL] [Abstract][Full Text] [Related]
2. An acid-independent antiulcer effect of M1 antimuscarinics in the rat.
Kromer W; Gönne S
Pharmacology; 1988; 37 Suppl 1():48-53. PubMed ID: 3237766
[TBL] [Abstract][Full Text] [Related]
3. Gastric antisecretory activity of telenzepine, a new M1-selective muscarinic antagonist: comparison with pirenzepine.
Coruzzi G; Adami M; Bertaccini G
Arch Int Pharmacodyn Ther; 1989; 302():232-41. PubMed ID: 2636819
[TBL] [Abstract][Full Text] [Related]
4. Effects of KW-5805, a new antiulcer agent, on experimental gastric and duodenal ulcers, gastric mucosal lesions by necrotizing agents and gastric acid secretion.
Kosaka N; Tanaka H; Tomaru A; Ishii A; Shuto K
Jpn J Pharmacol; 1994 Aug; 65(4):305-12. PubMed ID: 7990267
[TBL] [Abstract][Full Text] [Related]
5. Comparison of telenzepine, pirenzepine and atropine on gastric acid and pepsin secretion in response to histamine, pentagastrin, bethanechol, sham-feeding and feeding.
Konturek SJ; Tasler J; Cieszkowski M; Szewczyk K; Kromer W
Digestion; 1989; 44(2):66-78. PubMed ID: 2575551
[TBL] [Abstract][Full Text] [Related]
6. Effects of antimuscarinic agents and prostaglandin E2 on the gastric mucosal lesions induced by necrotizing agents and water-immersion stress in rats.
Kitagawa H; Hayashi T; Takeda F; Kinekawa F; Kohei H
Jpn J Pharmacol; 1986 Jul; 41(3):409-14. PubMed ID: 3463816
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of the gastric antisecretory activity of histamine H2-receptor antagonists by clebopride.
Fernández AG; Massingham R; Roberts DJ
Methods Find Exp Clin Pharmacol; 1988 May; 10(5):285-93. PubMed ID: 2899659
[TBL] [Abstract][Full Text] [Related]
8. Direct comparison between the ulcer-healing effects of two H(+)-K(+)-ATPase inhibitors, one M1-selective antimuscarinic and one H2 receptor antagonist in the rat.
Kromer W; Gönne S; Riedel R; Postius S
Pharmacology; 1990; 41(6):333-7. PubMed ID: 1982899
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological evidence for selective inhibition of gastric acid secretion by telenzepine, a new antimuscarinic drug.
Eltze M; Gönne S; Riedel R; Schlotke B; Schudt C; Simon WA
Eur J Pharmacol; 1985 Jun; 112(2):211-24. PubMed ID: 4029260
[TBL] [Abstract][Full Text] [Related]
10. Effects of atropine and pirenzepine on healing of gastric ulcer induced by mucosal excision in rats.
Sano M; Kitagawa H; Fujiwara M
Clin Ther; 1985; 7(3):380-9. PubMed ID: 3838920
[TBL] [Abstract][Full Text] [Related]
11. Gastric cytoprotection by pirenzepine in rats: evaluating method for cytoprotective activity by antisecretory agents.
Takeda F; Kitagawa H; Kohei H
Jpn J Pharmacol; 1985 Aug; 38(4):337-46. PubMed ID: 3865005
[TBL] [Abstract][Full Text] [Related]
12. [An experimental study of the antisecretory and antiulcer activities of kviditen].
Kaminka ME; Tupikina SM; Mashkovskiĭ MD
Eksp Klin Farmakol; 1994; 57(6):36-8. PubMed ID: 7756958
[TBL] [Abstract][Full Text] [Related]
13. Comparison between ranitidine, cimetidine, pirenzepine and placebo in the short term treatment of duodenal ulcer.
Giacosa A; Cheli R; Molinari F; Parodi MC
Scand J Gastroenterol Suppl; 1982; 72():215-9. PubMed ID: 6291138
[TBL] [Abstract][Full Text] [Related]
14. [3 mg telenzepine nocte in the treatment of benign stomach ulcer disease: a double-blind comparative study with 300 mg ranitidine nocte].
Simon B; Reinicke HG; Dammann HG; Müller P
Z Gastroenterol; 1990 Feb; 28(2):90-3. PubMed ID: 2181788
[TBL] [Abstract][Full Text] [Related]
15. The effect of the new H2-receptor antagonist mifentidine on gastric secretion, gastric emptying and experimental gastric and duodenal ulcers in the rat: comparison with cimetidine and ranitidine.
Scarpignato C; Tangwa M; Tramacere R; Del Soldato P
Digestion; 1986; 33(1):7-16. PubMed ID: 2866139
[TBL] [Abstract][Full Text] [Related]
16. [Acid anti-secretion therapy in gastric and duodenal ulcer].
Lattanzi A
Clin Ter; 1981 Oct; 99(2):187-205. PubMed ID: 6119184
[No Abstract] [Full Text] [Related]
17. [The endoscopic assessment of the effect of ranitidine and pirenzepine on the manifestations of the gastropathy induced by nonsteroidal anti-inflammatory preparations].
Karateev AE; Murav'ev IuV; Nasonova VA
Ter Arkh; 1997; 69(5):67-9. PubMed ID: 9235663
[TBL] [Abstract][Full Text] [Related]
18. Cimetidine, ranitidine and mifentidine in specific gastric and duodenal ulcer models.
Del Soldato P; Ghiorzi A; Cereda E; Donetti A
Pharmacology; 1985; 30(1):45-51. PubMed ID: 2858110
[TBL] [Abstract][Full Text] [Related]
19. Telenzepine, a new M1-receptor antagonist, is a more potent inhibitor of pentagastrin-stimulated gastric acid output than pirenzepine in dogs.
Holtmann G; Küppers U; Singer MV
Scand J Gastroenterol; 1990 Mar; 25(3):293-7. PubMed ID: 2320949
[TBL] [Abstract][Full Text] [Related]
20. Effects of cimetidine, atropine and pirenzepine on basal and stimulated gastric acid secretion in the rat.
Ekelund M; Håkanson R; Vallgren S
Eur J Pharmacol; 1987 Jun; 138(2):225-32. PubMed ID: 3622610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
